Puberty blockers are safe and effective treatments for transgender youth.
The safety and efficacy of puberty blockers for transgender youth remain contested, with studies pointing to mental health benefits and effective puberty suppression alongside documented risks to bone density, limitations in long-term safety data, and recent international policy shifts toward greater caution.
While multiple studies indicate that puberty blockers effectively suppress puberty and correlate with improved mental health outcomes for transgender adolescents, systematic reviews and recent clinical guidelines highlight important physical risks—such as impacts on bone mineral density—and substantial uncertainties regarding long-term effects. This has led to international division and stricter criteria in several jurisdictions, making the overall status contested.
The evidence we hold leans leans supported
How this was weighed
official record 3x · fact-check 2x · hedged 1x · crowd & reference 1x
- Effectiveness of Puberty Suppression with Gonadotropin-Relea · peer-reviewed · supports · weight 1.3 · 2021
- Use of gonadotropin-releasing hormone agonists in transgende · peer-reviewed · supports · weight 1.05 · 2025
- Mental Health of Youths Who Use Puberty Blockers. · peer-reviewed · supports · weight 1 · 2026
- Use of gonadotropin-releasing hormone agonists in transgende · peer-reviewed · refutes · weight 1.05 · 2025
- Healthcare providers' perceptions of changes in guidelines f · peer-reviewed · refutes · weight 1 · 2025
Juan Diego Mejia-Otero, Perrin White, Ximena Lopez. Effectiveness of Puberty Suppression with Gonadotropin-Releasing Hormone Agonists in Transgender Youth. 2021. https://doi.org/10.1089/trgh.2020.0007
Paper 0 establishes that GnRHa effectively suppresses puberty in transgender adolescents.
Tornese G, Di Mase R, Munarin J, Ciancia S, Santamaria F, Fava D, Candela E, Capalbo D, Ungaro C, Improda N, Diana P, Matarazzo P, Guazzarotti L, Toschetti T, Sambati V, Tamaro G, Bresciani G, Licenziati MR, Street ME, Aversa T, Delvecchio M, Faienza MF, Iughetti L, Calcaterra V, de Sanctis L, Salerno M, Franceschi R. Use of gonadotropin-releasing hormone agonists in transgender and gender diverse youth: a systematic review.. 2025. https://doi.org/10.3389/fendo.2025.1555186
Paper 3 highlights that long-term evidence on safety remains limited, with bone mineral density declining and uncertainties surrounding fertility and skeletal health.
See more details
Tornese G, Di Mase R, Munarin J, Ciancia S, Santamaria F, Fava D, Candela E, Capalbo D, Ungaro C, Improda N, Diana P, Matarazzo P, Guazzarotti L, Toschetti T, Sambati V, Tamaro G, Bresciani G, Licenziati MR, Street ME, Aversa T, Delvecchio M, Faienza MF, Iughetti L, Calcaterra V, de Sanctis L, Salerno M, Franceschi R. Use of gonadotropin-releasing hormone agonists in transgender and gender diverse youth: a systematic review.. 2025. https://doi.org/10.3389/fendo.2025.1555186
Paper 3 notes that GnRHa effectively halts puberty and is associated with significant improvements in mental health.
Kronk C, Jain R, Dai Y, Wolfe HL, Hughes L, Goetz TG, Jackson ST, Hardy DS, Kidd K, Reisner SL. Mental Health of Youths Who Use Puberty Blockers.. 2026. https://doi.org/10.1001/jamanetworkopen.2026.23302
Paper 8 finds that puberty blockers are associated with decreased adjusted odds of mood disorders and suicidal thoughts in transgender youth.
Svantesson E, Linander I. Healthcare providers' perceptions of changes in guidelines for care of minors with gender dysphoria in Sweden: An interview study.. 2025. https://doi.org/10.1371/journal.pone.0336950
Paper 10 discusses international shifts toward stricter criteria and a more cautious approach to prescribing puberty blockers to minors due to evolving guideline evaluations.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt